Scientific Sessions 2024  /  Multi-Omics for Assessing Disease Susceptibility and Identifying Novel Mechanisms  /  Platform Compatibility and Meta-analysis Approaches for High-Throughput Omics Platforms: The TOPMed Experience
Logo

American Heart Association

  2
  0

Final ID:

Platform Compatibility and Meta-analysis Approaches for High-Throughput Omics Platforms: The TOPMed Experience

  • Yu, Bing  ( UNIV OF TX HEALTH SCI CTR HOUSTON , Houston , Texas , United States )
  • Raffield, Laura  ( University of North Carolina at Chapel Hill , Chapel Hill , North Carolina , United States )
  • Feofanova, Elena  ( UTHSC Houston , Houston , Texas , United States )
    • Author Disclosures:
    Bing Yu: DO NOT have relevant financial relationships | Laura Raffield: DO NOT have relevant financial relationships | Elena Feofanova: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Multi-Omics for Assessing Disease Susceptibility and Identifying Novel Mechanisms

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Multi-Omics for Disentangling Clinical Heterogeneity: Heart Failure as a Paradigm

Ho Jennifer, Shah Sanjiv, Shah Svati

Human Perturbation Studies in Omics Research: Identifying Novel Biomarkers and Uncovering Disease Susceptibility

Nayor Matthew, Arora Pankaj, Mi Michael

More abstracts from these authors:
Soluble CD14 and Risk of Incident Cognitive Impairment: the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Ogunlana Emmanuel, Wilkinson Katherine, Sawyer Russell P., Raffield Laura, Plante Timothy, Cushman Mary, Olson Nels

Metabolomic Markers of Aortic Stenosis Development: the Atherosclerosis Risk in Communities (ARIC) Study

Shelbaya Khaled, Lamberson Victoria, Yang Yimin, Zhou Peidi, Alkis Taryn, Matsushita Kuni, Yu Bing, Shah Amil

You have to be authorized to contact abstract author. Please, Login
Not Available